US HB1188 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on February 13 2019 - 25% progression, died in committee
Action: 2019-02-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 13 2019 - 25% progression, died in committee
Action: 2019-02-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To shorten monopoly periods for prescription drugs that are the subjects of sudden price hikes.
Title
FLAT Prices Act Forcing Limits on Abusive and Tumultuous Prices
Sponsors
| Rep. Jared Golden [D-ME] | Rep. Sean Casten [D-IL] | Rep. Elissa Slotkin [D-MI] | Rep. Gil Cisneros [D-CA] |
| Rep. Max Rose [D-NY] | Rep. Chellie Pingree [D-ME] | Rep. Abby Finkenauer [D-IA] | Rep. Lloyd Doggett [D-TX] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-02-14 | House | Referred to the Subcommittee on Health. |
| 2019-02-13 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-02-13 | House | Introduced in House |
Same As/Similar To
SB366 (Same As) 2019-02-06 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Subjects
Business records
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/1188/all-info |
| Text | https://www.congress.gov/116/bills/hr1188/BILLS-116hr1188ih.pdf |
